T-cell therapy: unlocking success with the right culture medium
Developing a solid and efficacious T-cell therapy includes many hurdles and challenges. Although it has been a decade since the commercialization of the first CAR-T cell therapy, we are still just at the beginning of understanding their full potential. As a raw material supplier specializing in cell and gene therapies, experts from Sartorius CellGenix (Freiburg, Germany) will share their knowledge on critical process parameters and factors that need to be considered when looking for suitable raw materials for T-cell therapy manufacturing.
What will you learn?
- Critical process parameters during CAR-T and T-cell manufacturing
- How can the right cell culture medium influence your cell therapy product
- Important factors to consider early in the development phase
- Insights on the performance of the novel CellGenix® GMP TCM
Who may this interest?
- Anyone involved in the development of T-cell therapies
- Process development Scientists at biotech/pharma/CDMO
- Process Engineers at biotech/pharma/CDMO
Speaker
Evelien Nijssen
Manager of Marketing and Product Management
Sartorius CellGenix (Freiburg, Germany)
Evelien Nijssen is the Manager of Marketing and Product Management at Sartorius CellGenix, overseeing the GellGenix portfolio in the cell and gene therapy space.
In association with
This webinar was recorded on 29 June 2023